Latest Circulating Tumor Cell Stories
Scientists from The Scripps Research Institute, Scripps Health, and collaborating cancer physicians have successfully demonstrated the effectiveness of an advanced blood test for detecting and analyzing circulating tumor cells (CTCs)—breakaway cells from patients' solid tumors—from cancer patients.
The characterization of these cells will allow individualized follow-up of cancer patients, and the development of more efficient therapies.
Researchers have developed a method to analyze circulating tumor cells in the blood of patients with non-small cell lung cancer.
The presence of circulating tumor cells in the blood appears to have no relationship to survival in women who have just been diagnosed with inflammatory breast cancer.
The removal of rare tumor cells circulating in the blood might be possible with the use of biomolecules bound to dendrimers, highly branched synthetic polymers, which could efficiently sift and capture the diseased cells.
- A poem in which the author retracts something said in an earlier poem.